ignificance of distinct specifically enriched missense TP53 mutations in prostate cancer

被引：0

作者：

Vasilevskaya, Irina ^{[1
]}

McCann, Jennifer ^{[1
]}

McNair, Christopher ^{[1
]}

Neupane, Neermala Poudel ^{[1
]}

Gallagher, Peter ^{[1
]}

Knudsen, Karen E. ^{[1
]}

机构：

[1] Jefferson Univ, Sidney Kimmel Canc Ctr, Philadelphia, PA USA

来源：

JOURNAL OF CLINICAL ONCOLOGY | 2020年 / 38卷 / 06期

基金：

美国国家卫生研究院;

关键词：

D O I：

暂无

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

377

引用

页数：1

共 50 条

[41] Analytic, Preanalytic, and Clinical Validation of p53IHC for Detection of TP53 Missense Mutation in Prostate Cancer
Guedes, Liana B.
Almutairi, Fawaz
Haffner, Michael C.
Rajoria, Gaurav
Liu, Zach
Klimek, Szczepan
Zoino, Roberto
Yousefi, Kasra
Sharma, Rajni
De Marzo, Angelo M.
Netto, George J.
Isaacs, William B.
Ross, Ashley E.
Schaeffer, Edward M.
Lotan, Tamara L.
CLINICAL CANCER RESEARCH, 2017, 23 (16) : 4693 - 4703
[42] Molecular mechanism in prostate cancer with TP53 mutation
Hu, B.
Liu, H.
Zhang, Y.
Wang, H.
ANNALS OF ONCOLOGY, 2022, 33 : S1606 - S1606
[43] Inherited TP53 Variants and Risk of Prostate Cancer
Maxwell, Kara N.
Cheng, Heather H.
Powers, Jacquelyn
Gulati, Roman
Ledet, Elisa M.
Morrison, Casey
Le, Anh
Hausler, Ryan
Stopfer, Jill
Hyman, Sophie
Kohlmann, Wendy
Naumer, Anne
Vagher, Jennie
Greenberg, Samantha E.
Naylor, Lorraine
Laurino, Mercy
Konnick, Eric Q.
Shirts, Brian H.
AlDubayan, Saud H.
Van Allen, Eliezer M.
Nguyen, Bastien
Vijai, Joseph
Abida, Wassim
Carlo, Maria, I
Dubard-Gault, Marianne
Lee, Daniel J.
Maese, Luke D.
Mandelker, Diana
Montgomery, Bruce
Morris, Michael J.
Nicolosi, Piper
Nussbaum, Robert L.
Schwartz, Lauren E.
Stadler, Zsofia
Garber, Judy E.
Offit, Kenneth
Schiffman, Joshua D.
Nelson, Peter S.
Sartor, Oliver
Walsh, Michael F.
Pritchard, Colin C.
EUROPEAN UROLOGY, 2022, 81 (03) : 243 - 250
[44] TP53 Deficiency in the Natural History of Prostate Cancer
Ofner, Heidemarie
Kramer, Gero
Shariat, Shahrokh F.
Hassler, Melanie R.
CANCERS, 2025, 17 (04)
[45] Mutational landscape of TP53 in localized prostate cancer
Mahamud, Osman
Chua, Melvin L. K.
Supiot, Stephane
Lalonde, Emilie
Dal Pra, Alan
Berlin, Alejandro
Orain, Michele
Picard, Valerie
Hovington, Helene
Bergeron, Alain
Fradet, Yves
Tetu, Bernard
Zafarana, Gaetano
Meng, Alice
Livingstone, Julie
Pintilie, Melania
Fraser, Michael
van der Kwast, Theodorus
Boutros, Paul C.
Robert, Bristow G.
MOLECULAR CANCER RESEARCH, 2017, 15
[46] Recurrent TP53 missense mutation in cancer patients of Arab descent
Aviad Zick
Luna Kadouri
Sherri Cohen
Michael Frohlinger
Tamar Hamburger
Naama Zvi
Morasha Plaser
Eilat Avital
Shani Breuier
Firase Elian
Azzam Salah
Yael Goldberg
Tamar Peretz
Familial Cancer, 2017, 16 : 295 - 301
[47] Recurrent TP53 missense mutation in cancer patients of Arab descent
Zick, Aviad
Kadouri, Luna
Cohen, Sherri
Frohlinger, Michael
Hamburger, Tamar
Zvi, Naama
Plaser, Morasha
Avital, Eilat
Breuier, Shani
Elian, Firase
Salah, Azzam
Goldberg, Yael
Peretz, Tamar
FAMILIAL CANCER, 2017, 16 (02) : 295 - 301
[48] TP53 Mutations and Lung Cancer: Not All Mutations Are Created Equal
Govindan, Ramaswamy
Weber, Jason
CLINICAL CANCER RESEARCH, 2014, 20 (17) : 4419 - 4421
[49] Prognostic value genotypes and LOH at TP53 codon 72 and TP53 mutations in primary breast cancer
Kyndi, M
Alsner, J
Hansen, LL
Sorensen, FB
Overgaard, J
BREAST CANCER RESEARCH, 2005, 7 (Suppl 2) : S54 - S54
[50] Immune pathways and TP53 missense mutations are associated with longer survival in canine osteosarcoma
Sunetra Das
Rupa Idate
Daniel P. Regan
Jared S. Fowles
Susan E. Lana
Douglas H. Thamm
Daniel L. Gustafson
Dawn L. Duval
Communications Biology, 4

← 1 2 3 4 5 →